Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | The impact of age on COVID-19 outcomes in patients

Lisa Hicks • 16 Dec 2021
ASH 2021
General

Lisa Hicks, MD, MSc, St. Michael’s Hospital, Toronto, Canada, discusses the role age plays in determining COVID-19 outcomes and treatment patterns in patients with hematologic malignancies. Analysis from the ASH Research Collaborative (RC) COVID-19 Registry for Hematology revealed that the rate of symptomatic and asymptomatic cancer was similar across age ranges, with reported symptoms including fever, coughing, and shortness of breath being consistent across patients. However, the presence of co-morbidities was increased in older patients and when taking into account gender, younger women tended to fare better, whilst older men had inferior outcomes. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

More from Lisa Hicks

4:55
COVID-19-related risk factors in patients with blood cancers
Lisa Hicks • 16 Dec 2021
4:45
COVID-19 risk factors in patients with hematologic malignancies
Lisa Hicks • 11 Dec 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals